Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Regulating microbiome manipulation

A crucial consideration for the clinical application of any burgeoning science is when the understanding of that field can be implemented without the risk of unforeseen harm. In our opinion, the need for caution is particularly urgent with respect to increasingly prevalent applications of microbiome science to medicine.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Carlucci, C., Petrof, E. O. & Allen-Vercoe, E. EBioMedicine 13, 37–45 (2016).

    Article  Google Scholar 

  2. 2.

    van Nood, E. et al. N. Engl. J. Med. 368, 407–415 (2013).

    Article  Google Scholar 

  3. 3.

    Gupta, A., Cifu, A. S. & Khanna, S. JAMA 320, 1031–1032 (2018).

    Article  Google Scholar 

  4. 4.

    Hoffman, D. et al. Science 358, 1390–1391 (2017).

    Article  Google Scholar 

  5. 5.

    Sachs, R. E. & Edelistein, C. A. J. Law Biosci. 6, 396–415 (2015).

    Article  Google Scholar 

  6. 6.

    Woodworth, M. H. et al. New Bioeth. 23, 210–218 (2017).

    Article  Google Scholar 

  7. 7.

    Woodworth, M. H. et al. J. Clin. Micro. 55, 1002–1010 (2017).

    CAS  Article  Google Scholar 

  8. 8.

    Enforcement Policy Regarding Investigational New Drug Requirements for use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection not Responsive to Standard Therapies. Draft Guidance for Industry (US FDA, 2016).

  9. 9.

    Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion: Draft Guidance for Industry (ed. Center for Biologics Evaluation and Research) (US FDA, 2016).

  10. 10.

    Kristensen, N. B. et al. Genome Med. 8, 52 (2016).

    Article  Google Scholar 

  11. 11.

    Thomas, S. et al. Cancer Res. 77, 1783–1812 (2017).

    CAS  Article  Google Scholar 

  12. 12.

    Aagaard, K. FASEB J. 27, 1012–1022 (2012).

    Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Kjersti Aagaard.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Aagaard, K., Hohmann, E. Regulating microbiome manipulation. Nat Med 25, 874–876 (2019).

Download citation

Further reading


Quick links